共 36 条
[1]
Giembycz, M.A., Dent, G., Souness, J.E., Theophylline and isoenzyme-selective phosphodiesterase inhibitors (1997) Allergy and Allergic Diseases, pp. 531-567. , Kay, A. B., ed., Blackwell Scientific
[2]
Torphy, T.J., Undem, B.J., (1991) Phosphodiesterase Inhibitors: New Opportunities for the Treatment of Asthma. I, 46, pp. 512-523
[3]
Giembycz, M.A., Could isoenzyme-selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma? (1992) Biochem. Pharmacol., 43, pp. 2041-2051
[4]
Giembycz, M.A., Dent, G., Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthma (1992) Clin. Exp. Allergy, 22, pp. 337-344
[5]
Nicholson, C.D., Shahid, M., Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes - Their potential utility in the therapy of asthma (1994) Pulmonary Pharmacol., 7, pp. 1-17
[6]
Dent, G., Giembycz, M.A., Selective phosphodiesterase inhibitors in the therapy of asthma (1995) Clin. Immunother., 3, pp. 423-437
[7]
Dent, G., Giembycz, M.A., Phosphodiesterase inhibitors: Lily the Pink's medicinal compound for asthma? (1996) Thorax, 51, pp. 647-649
[8]
Hughes, B., Owens, R., Perry, M., Warrellow, G., Allen, R., PDE 4 inhibitors: The use of molecular cloning in the design and development of novel drugs (1997) Drug Discovery Today., 2, pp. 89-101
[9]
Seldon, P.M., Barnes, P.J., Meja, K., Giembycz, M.A., Suppression of lipopolysaccharide-induced tumor necrosis factor-α generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: Interaction with stimulants of adenylyl cyclase (1995) Mol. Pharmacol., 48, pp. 747-757
[10]
Prabhakar, U., Lipshutz, D., Bartus, J.O., Slivjak, M.J., Smith, E.F., Lee, J.C., Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor (1994) Int. J. Immunopharmacol., 16, pp. 805-816